These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
115 related items for PubMed ID: 6149731
1. Effect of some beta adrenergic blocking agents and phenytoin on potentiation of quinidine antiarrhythmic activity in the mouse. Lawson JW. Arch Int Pharmacodyn Ther; 1984 Jul; 270(1):106-15. PubMed ID: 6149731 [Abstract] [Full Text] [Related]
2. Comparative antiarrhythmic activity of quinidine combined with propranolol and with sotalol. Lawson JW, Wojciechowski NJ. Arch Int Pharmacodyn Ther; 1981 Jan; 249(1):72-86. PubMed ID: 6111984 [Abstract] [Full Text] [Related]
3. Inhibition of quinidine-propranolol elevation of the ventricular fibrillation threshold by bilateral stellectomy+vagotomy in the anesthetized dog. Lawson JW. Arch Int Pharmacodyn Ther; 1986 Mar; 280(1):74-83. PubMed ID: 3718083 [Abstract] [Full Text] [Related]
4. Protective effects of different beta-blocking agents against electroshock lethality in mice. Pérez-Ojeda E, Hernandez J, Serrano JS. J Pharmacol; 1983 Mar; 14(3):303-9. PubMed ID: 6138460 [Abstract] [Full Text] [Related]
8. Mechanism of action of quinidine on heart rate in the dog. Chassaing C, Duchene-Marullaz P, Paire M. J Pharmacol Exp Ther; 1982 Sep; 222(3):688-93. PubMed ID: 6286932 [Abstract] [Full Text] [Related]
11. [Pharmacological properties of dl-2-(3'-t-butylamino-2'-hydroxypropylthio)-4-(5'-carbamoyl-2'-thienyl) thiazole hydrochloride (S-596), a new beta-adrenergic blocking agent (author's transl)]. Hara Y, Sato E, Miyagishi A, Aono S, Nakatani H. Nihon Yakurigaku Zasshi; 1979 Oct; 75(7):707-20. PubMed ID: 94296 [Abstract] [Full Text] [Related]
12. The clinical pharmacology of antiarrhythmic drugs. Part II: Quinidine, propranolol, diphenylhydantoin, and bretylium. Levitt B, Borer JS, Sarapa A. Cardiovasc Nurs; 1974 Oct; 10(6):27-31. PubMed ID: 4498549 [No Abstract] [Full Text] [Related]
14. A cardiac antiarrhythmic screening test in the rat: the effects of lidocaine, propranolol and quinidine. Baker T, Erker EF. Arch Int Pharmacodyn Ther; 1980 Jan; 243(1):97-102. PubMed ID: 7387264 [Abstract] [Full Text] [Related]
15. A microelectrophysiological analysis of the pharmacodynamic basis for quinidine-propranolol antiarrhythmic potentiation. Iansmith DH, Bandura JP, Nash CB. J Pharmacol Exp Ther; 1981 Dec; 219(3):651-8. PubMed ID: 7299688 [No Abstract] [Full Text] [Related]
16. Pharmacology of aconitine-induced automaticity on in vitro cat myocardial preparations. II. Effects of refractory period prolongation, reduced sodium and tetrodotoxin. Tanz RD. J Pharmacol Exp Ther; 1974 Nov; 191(2):232-40. PubMed ID: 4153868 [No Abstract] [Full Text] [Related]
20. Role of the cholinergic system in the modulation of ventricular arrhythmias induced by subepicardial epinephrine in the dog. Das PK, Bhattacharya TK, Gambhir SS. Adv Myocardiol; 1985 Nov; 6():349-65. PubMed ID: 2581298 [Abstract] [Full Text] [Related] Page: [Next] [New Search]